Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

354
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
Angina IV: Management01:26

Angina IV: Management

368
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

538
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
538
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

358
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

465
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Slow-growing hematoma in the thoracic ligamentum flavum: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Electrosynthetic bacterial growth under conditions simulating electric discharge in deep-sea hydrothermal fields.

The ISME journal·2026
Same author

Aged garlic extract suppressed macrophage-mediated inflammation in acute respiratory distress syndrome.

Food & function·2026
Same author

Impact of cerebral venous reflux on functional outcome in patients with acute lacunar stroke.

AJNR. American journal of neuroradiology·2026
Same author

A noninvasive urinary microRNA-based assay for early detection of lung cancer and its potential application to prognosis and recurrence monitoring: a case-control study.

NPJ precision oncology·2026
Same author

Continuous sedation in adolescent and young adult cancer patients under home-based end-of-life care.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Related Experiment Video

Updated: Mar 7, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

Cognitive Change 1 Year after CEA or CAS Compared with Medication.

Junko Watanabe1, Toshiyasu Ogata2, Toshio Higashi3

  • 1Department of Rehabilitation, Fukuoka University Hospital, Fukuoka University, Fukuoka 814-0180, Japan; Department of Neurosurgery, Faculty of Medicine, Fukuoka University, Fukuoka University Hospital, Fukuoka 814-0180, Japan.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|February 26, 2017
PubMed
Summary

Carotid endarterectomy (CEA) and carotid artery stenting (CAS) may improve cognitive function, particularly executive and memory domains, as measured by the Montreal Cognitive Assessment (MoCA). Medical treatment alone did not show similar cognitive benefits.

Keywords:
CASCEACognitioncarotid stenosisfollow-upmedication

More Related Videos

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

753
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

Related Experiment Videos

Last Updated: Mar 7, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K
A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

753
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

Area of Science:

  • Neurology
  • Vascular Surgery
  • Cognitive Science

Background:

  • Cognitive function maintenance after carotid interventions is debated.
  • Carotid stenosis poses risks to cerebral blood flow and cognitive health.

Purpose of the Study:

  • To assess cognitive changes 1 year post-carotid endarterectomy (CEA) or carotid artery stenting (CAS).
  • To compare cognitive outcomes between CEA, CAS, and medical management for carotid stenosis.

Main Methods:

  • Prospective study of patients with carotid stenosis undergoing CEA, CAS, or medical treatment.
  • Cognitive function evaluated using Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) pre- and post-intervention.
  • Statistical analysis using Wilcoxon signed rank test for cognitive score changes.

Main Results:

  • Montreal Cognitive Assessment (MoCA) scores significantly improved 1 year after CEA (21 to 23) and CAS (P<0.05).
  • Mini-Mental State Examination (MMSE) scores showed no significant change after CEA or CAS.
  • CEA improved executive and memory functions; medical treatment improved memory only. CAS did not improve any subscores.

Conclusions:

  • Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are associated with significant cognitive improvement, particularly as measured by MoCA.
  • Medical management alone did not demonstrate comparable cognitive improvements.
  • MoCA appears more sensitive than MMSE in detecting cognitive changes after carotid interventions.